Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Mycobacterial antigen presentation enhancement via phagolysosomal escape" describes a process by which Mycobacterium tuberculosis (Mtb) evades macrophage killing by escaping from the phagosome into the cytosol of the host cell. This escape, mediated by factors like the ESX-1 secretion system and ESAT-6 protein, enables bacterial antigens to access the cytosolic major histocompatibility complex class I (MHC-I) processing pathway and impacts both pathogen survival and host immune recognition. The process enhances mycobacterial virulence, supports immune evasion, and modulates how antigens are presented to T cells, but is not a targetable molecule in itself[1][2][3][4][6].
Enhancement or inhibition of mycobacterial ESX-1/ESAT-6 secretion system may modulate escape and antigen presentation. Phagosome maturation promotion (general immunomodulatory strategies). No drugs act directly on the process named here; this is a general immunological concept rather than a ligand–receptor or enzyme–inhibitor interaction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mycobacterial antigen presentation enhancement via phagolysosomal escape.